doi:10.3969/j.issn.1673-8640.2024.06.015

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 16

[1]	中华医学会, 中华医学会杂志社, 中华医学会消化病学分会, 等. 急性胰腺炎基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(9):819-826.
[2]	YI K Q, YANG T, YANG Y M, et al. Appraisal of the diagnostic procedures of acute pancreatitis in the guidelines[J]. Syst Rev, 2021, 10(1):17.
[3]	HARSHIT KUMAR A, SINGH GRIWAN M. A comparison of APACHE Ⅱ,BISAP,Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification[J]. Gastroenterol Rep(Oxf), 2018, 6(2):127-131.
[4]	MA K, QIU H, ZHU Y, et al. Preprocedural SⅡ combined with high-sensitivity C-reactive protein predicts the risk of contrast-induced acute kidney injury in STEMI patients undergoing percutaneous coronary intervention[J]. J Inflamm Res, 2022, 15:3677-3687.
[5]	LU X, WAN J, SHI H. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios are associated with the efficacy of immunotherapy in stage Ⅲ/Ⅳ non-small cell lung cancer[J]. Oncol Lett, 2022, 24(2):266.
[6]	ELSARAYA N, GORDON-IRSHAI A, SCHWARZFUCHS D, et al. Neutrophil to lymphocyte ratio as an early indicator for ureteral catheterization in patients with renal colic due to upper urinary tract lithiasis[J]. PLoS One, 2022, 179(6):e0270706.
[7]	尹宏祥, 段家康, 江博文, 等. 全身免疫炎症指数联合预后营养指数对接受根治性切除术的肝细胞癌的预后价值研究[J]. 中华普通外科学文献(电子版), 2023, 17(2):93-98.
[8]	朱梦柳, 陈力, 孔祥溢, 等. 全身炎症反应指数(SIRI)在乳腺癌患者中的临床意义和预后价值[J]. 现代肿瘤医学, 2022, 30(3):442-450.
[9]	屠夏敏, 李瑶瑶, 王远志, 等. 全身免疫炎症指数对重度急性胰腺炎的预测价值[J]. 胃肠病学, 2022, 27(2):92-96.
[10]	许海梅, 郭春宣, 李永超, 等. 营养风险指数、全身免疫炎症指数和三酰甘油葡萄糖指数预测急性胰腺炎患者病情及预后的价值[J]. 西安交通大学学报(医学版), 2023, 44(4):577-582.
[11]	LIU X, GUAN G, CUI X, et al. Systemic immune-inflammation index(SⅡ) can be an early indicator for predicting the severity of acute pancreatitis:a retrospective study[J]. Int J Gen Med, 2021, 14:9483-9489.
[12]	蔡健华, 何嘉琦, 刘猛, 等. 预后营养指数在胰头和壶腹周围癌腹腔镜胰十二指肠切除术后患者预后中的价值[J]. 中华肝脏外科手术学电子杂志, 2020, 9(5):439-444.
[13]	邵全年, 周辉年, 肖竞英, 等. 基于术前NLR及PNI的胰腺癌根治术预后预测模型的构建及评价[J]. 解放军医学杂志, 2021, 46(10):1009-1017.
[14]	桂恩杨, 孙学虎, 王兴宇. 中性粒细胞与淋巴细胞比值作为重症急性胰腺炎早期预测指标的临床研究[J]. 肝胆外科杂志, 2021, 29(3):187-190.
[15]	刘媛媛, 祝壮, 王秋月, 等. 中性粒细胞/淋巴细胞比值与急性胰腺炎严重程度及全身并发症的关系[J]. 临床消化病杂志, 2020, 32(2):108-112.
[16]	CHO S K, JUNG S, LEE K J, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio can predict the severity of gallstone pancreatitis[J]. BMC Gastroenterol, 2018, 18(1):18. DOI PMID

组别	例数	年龄/岁	性别		病因
组别	例数	年龄/岁	男/[例（%）]	女/[例（%）]	胆源性/[例（%）]	其他/[例（%）]
NSAP组	226	43.0（34.0~56.0）	156（69.0）	70（31.0）	106（46.9）	120（53.1）
SAP组	79	48.0（34.5~65.5）	47（59.5）	22（40.5）	40（50.6）	39（49.4）
统计值		-1.925	0.020		0.326
P值		0.054	0.886		0.568

组别	例数	年龄/岁	性别		病因
组别	例数	年龄/岁	男/[例（%）]	女/[例（%）]	胆源性/[例（%）]	其他/[例（%）]
NSAP组	226	43.0（34.0~56.0）	156（69.0）	70（31.0）	106（46.9）	120（53.1）
SAP组	79	48.0（34.5~65.5）	47（59.5）	22（40.5）	40（50.6）	39（49.4）
统计值		-1.925	0.020		0.326
P值		0.054	0.886		0.568

组别	例数	中性粒细胞/（×10⁹·L^-1）	淋巴细胞/（×10⁹·L^-1）	血小板计数/（×10¹²·L^-1）	白蛋白/（g·L^-1）
NSAP组	226	8.76±4.62	1.31（0.92~1.71）	205（169~244）	37.3（34.3~40.8）
SAP组	79	11.74±4.45	0.98（0.59~1.29）	197（141~248）	34.3（29.6~37.4）
统计值		-4.972	-4.546	-0.642	-4.991
P值		<0.001	<0.001	0.751	<0.001

组别	例数	中性粒细胞/（×10⁹·L^-1）	淋巴细胞/（×10⁹·L^-1）	血小板计数/（×10¹²·L^-1）	白蛋白/（g·L^-1）
NSAP组	226	8.76±4.62	1.31（0.92~1.71）	205（169~244）	37.3（34.3~40.8）
SAP组	79	11.74±4.45	0.98（0.59~1.29）	197（141~248）	34.3（29.6~37.4）
统计值		-4.972	-4.546	-0.642	-4.991
P值		<0.001	<0.001	0.751	<0.001

炎症指标	曲线下面积（95%可信区间）	最佳临界值	敏感性/%	特异性/%	约登指数
中性粒细胞	0.693（0.629~0.757）	7.865×10⁹·L^-1	82.3	48.2	0.305
淋巴细胞	0.672（0.603~0.741）	1.355×10⁹·L^-1	81.0	47.8	0.288
白蛋白	0.689（0.620~0.757）	32.75 g·L^-1	44.3	82.7	0.270
C反应蛋白	0.736（0.661~0.810）	133.3 mg·L^-1	62.3	76.9	0.392
NLR	0.753（0.693~0.813）	6.802	82.3	55.8	0.381
炎症指标	曲线下面积	最佳临界值	敏感性/%	特异性/%	约登指数
血小板/淋巴细胞比值	0.675	168.7	74.7	55.8	0.305
SII	0.747	1 763	79.8	67.3	0.471
PNI	0.722	42.95	79.8	54.9	0.347
SII+PNI+NLR+ C反应蛋白	0.783	0.254 7	83.6	64.2	0.478

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 16

Related Articles 15

Recommended Articles

Metrics

[1]	LIU Xiaowen, SHAO Wenqi, ZHU Jing, YANG Jing, ZHANG Chunyan, PAN Baishen, WANG Beili, GUO Wei. Establishment of reference interval of serum ferritin in adults in Shanghai by indirect method [J]. Laboratory Medicine, 2024, 39(6): 524-529.
[2]	CHENG Yan, ZHANG Ning, DONG Li, LING Xiaoming, WANG Yue, CHEN Guiqin, JING Shuang, CHEN Yannan. Expressions of MFG-E8 and GNA14 in endometriosis associated ovarian cancer [J]. Laboratory Medicine, 2024, 39(6): 530-535.
[3]	LOU Zhan, PENG Tao, LIU Xingliang, YUE Binghong, LI Ran, ZHI Yongyi. Expression of mitochondrial autophagy signaling pathway PINK1/Parkin and its relationship with neural function in patients with vascular Parkinsonism [J]. Laboratory Medicine, 2024, 39(6): 542-547.
[4]	CHEN Haiying, GE Yafang, PAN Shun, YANG Haiou. Clinical value of inflammatory derived indicators and cystatin C in preeclampsia [J]. Laboratory Medicine, 2024, 39(6): 557-561.
[5]	JIANG Jingjing, GU Ping, WANG Chengyun, ZHANG Fan, SHEN Huiying, PAN Qiuhui, WANG Jing. Changes and clinical significance of procalcitonin and coagulation function indicators in children with sepsis [J]. Laboratory Medicine, 2024, 39(6): 573-577.
[6]	. [J]. Laboratory Medicine, 2024, 39(6): 602-607.
[7]	LIU Junfeng, JIA Kegang, CHE Anqi, JING Rui, LI Yongshu, HAN Xuejing, SHI Ping, WU Meng, LIN Wenhua. Relation of AGGF1 in peripheral blood and coronary artery stenosis [J]. Laboratory Medicine, 2024, 39(5): 423-428.
[8]	ZHANG Xiaoke, CHU Yanrong, WANG Rong, CUI Facai. Serum lncRNA HAND2-AS1 expression in cervical cancer patients and its effect on proliferation，invasion and migration of cervical cancer Caski cells [J]. Laboratory Medicine, 2024, 39(5): 429-437.
[9]	LIU Xuewei, LI Kunpeng, SONG Junyu, ZHAO An. Relation between Apelin，IRS-2 protein and prognosis of gastric cancer patients [J]. Laboratory Medicine, 2024, 39(5): 438-442.
[10]	GU Liangliang, WANG Jianfeng, QIAO Xin, ZHANG Baochao, FU Guohui. Correlation between serum LRG1 level and cognitive impairment and recurrence in patients with acute ischemic stroke [J]. Laboratory Medicine, 2024, 39(5): 443-448.
[11]	ZHANG Na, LI Jing, YAN Xiaojing, ZHANG Lan, LIU Weixiao. Roles of IP-10 and MCP-1 in cerebrospinal fluid of children with viral encephalitis [J]. Laboratory Medicine, 2024, 39(5): 454-457.
[12]	MA Liyuan, YU Xiaohui, ZHANG Ningyu. Relation between peripheral blood cell score combined with IL-32 and prognosis of patients undergoing surgical treatment for multiple myeloma [J]. Laboratory Medicine, 2024, 39(5): 458-463.
[13]	DU Jinlong, LU Hong. Clinical roles of serum DHEA-S，SHBG and 17α-OHP in patients with polycystic ovary syndrome [J]. Laboratory Medicine, 2024, 39(5): 464-467.
[14]	ZHOU Fangfang, GU Xuemei, WANG Wei, LIN Ming, WANG Lei. Establishment and application of main components of Huang-Lian-Jie-Du decoction based on high performance liquid chromatography [J]. Laboratory Medicine, 2024, 39(5): 468-473.
[15]	ZHOU Ruiling, ZHANG Xinyu, REN Xiaoling, ZHANG Wen, FAN Changzheng, ZHANG Qiong. Relationship between uric acid/creatinine ratio and neutrophil/lymphocyte ratio and hypoxemia in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Laboratory Medicine, 2024, 39(5): 474-479.